Walgreens EBITDA 2010-2024 | WBA

Walgreens EBITDA for the quarter ending November 30, 2024 was $0.371B, a 40.06% decline year-over-year.

  • Walgreens 2024 EBITDA was -11.405B, a 160.86% increase from 2023.
  • Walgreens 2023 EBITDA was -4.372B, a 215.14% decline from 2022.
  • Walgreens 2022 EBITDA was 3.797B, a 19.55% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Walgreens EBITDA 2010-2024 | WBA

  • Walgreens 2024 EBITDA was -11.405B, a 160.86% increase from 2023.
  • Walgreens 2023 EBITDA was -4.372B, a 215.14% decline from 2022.
  • Walgreens 2022 EBITDA was 3.797B, a 19.55% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
CVS Health (CVS)$71.6B
Herbalife (HLF)$582M
China Jo-Jo Drugstores Holdings (CJJD)$11M
GNC Holdings (GNC)$0M